Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1178 |
Name of the vaccine | SA4AG |
Microbe | Bacteria |
Disease name | Methicillin-Resistant Staphylococcus aureus (MRSA) |
Name of bacteria | Staphylococcus aureus |
Type of vaccine | Polysaccharide |
Nucleic acid content | Circular DNA |
Age | 18 to 85 years |
Description of the vaccine | S. aureus 4-antigen vaccine (SA4Ag). |
Name of the manufacturer | Pfizer |
Name of the manufacturing country | Austria, Bulgaria, Canada, France, Germany, Hungary, Japan, Spain, Sweden, United Kingdom, United States |
Year of manufacture | 2019 |
Clinical Phase status | Clinical - Terminated |
Bacterial strain | Gram-positive bacteria. |
Efficacy | NA |
Vaccine formulation | Reconstituted in 0.5mL water for injection. |
Dosage | Single dose. |
Mechanism of action | Targets S. aureus virulence factors. |
Route of administration | Intramuscular |
Indications | Prevents postoperative Staphylococcus aureus infections. |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Single dose |
Interspecies transfer | NA |
PubMed identifier | 27916408 |
Clinical trial number | NCT02388165 |
Reference | NA |
Other name | NA |
Additional Links | NA |